Table 1

Epidemiological and clinical characteristics of HIV-infected and HIV-uninfected children with candidiasis diagnoses from 1997 to 2008
HIV-uninfected children HIV-infected children
All candidiasis Non-ICM ICM (a)p-value All candidiasis Non-ICM ICM (a)p-value (b)p-value (c)p-value (d)p-value
N 26 16 10 141 120 21
Males # 10 (38.5) 8 (50.0) 2 (20.0) 0.264 70 (49.6) 56 (46.7) 14 (66.7) 0.145 0.403 1 0.041
Age (years) * 0.5 (0; 8.7) 0 (0; 3.2) 9 (1.5; 11.0) 0.008 7 (1; 11) 7 (1; 11) 4 (2; 11) 0.921 0.016 <0.001 <0.001
Length of stay (days) * 6.5 (3.2; 10.5) 5.5 (3.0; 7.5) 8.5 (7.0; 22.0) 0.125 13 (7; 22) 12 (7; 22) 18 (9; 42) 0.049 0.006 <0.001 <0.001

Values expressed as: (#) Absolute number (percentage); (*) Median (percentile 25; percentile 75).

Abbreviations: ICM, invasive candidiasis mycosis; HIV, Human immunodeficiency virus.

Significance level (p-values): (a), Non-ICM vs. ICM within a group; (b), all candidiasis between groups, (c); Non-ICM between groups, (d), ICM between groups.

Statistically significant differences are shown in bold.

Álvaro-Meca et al.

Álvaro-Meca et al. BMC Infectious Diseases 2013 13:115   doi:10.1186/1471-2334-13-115

Open Data